Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109184 · ClinicalTrials.gov registry record · NA
Violence Prevention for Middle School Boys
A NA study of Intimate Partner Violence, sponsored by Northeastern University.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT03109184: Completed NA study of Intimate Partner Violence, sponsored by Northeastern University.
NCT03109184 is a NA study of Intimate Partner Violence that has completed, run by Northeastern University. The registered enrollment target is 119 participants, below the 349-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03109184, a NA study of Intimate Partner Violence, has completed, sponsored by Northeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop and test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.
Primary Outcome
The Conflict in Adolescent Dating Relationships Inventory (CADRI) is a behavioral measure of abuse perpetration and victimization. It was completed by teens in reference to conflict or disagreement with a current or recent dating partner. Each question is asked twice, first regarding perpetration and, again in relation to victimization producing a perpetration and a victimization sub scale. Percentages include teens endorsing any perpetration or victimization.
Conditions Studied
Interventions
- BEHAVIORAL Project STRONG
Study Locations (1)
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03109184 record still lists
NCT03109184 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 349-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Intimate Partner Violence appearing as the primary indexed condition, and to 1 intervention - of which Project STRONG is the first listed.
NCT03109184 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03109184 about?
NCT03109184 is a clinical study titled "Violence Prevention for Middle School Boys". This study will develop and test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.
What is the current status of trial NCT03109184?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2015-01-01. Estimated completion is 2018-12-31.
What conditions does trial NCT03109184 study?
This clinical trial studies the following conditions: Intimate Partner Violence.
What interventions are being tested in trial NCT03109184?
The interventions under investigation include: Project STRONG (BEHAVIORAL).
Who is sponsoring clinical trial NCT03109184?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03109184 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intimate Partner Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03109184's enrollment target sits among peer trials
119 10th of 14 higher than 5 of 14 other Intimate Partner Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intimate Partner Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Village for Young Parents
RECRUITING · NA
-
Multifaceted Intervention to Restore Resilience and Overcome Risk
RECRUITING · NA
-
Empowering Young Parents: Building Healthy Relationships Study
RECRUITING · NA
-
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
RECRUITING · NA
-
Evaluating Interventions for Intimate Partner Violence Use in Washington State
RECRUITING · NA
-
Perceptions of Trauma and Violence Informed Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI